0001354457-22-000658.txt : 20221121
0001354457-22-000658.hdr.sgml : 20221121
20221121085604
ACCESSION NUMBER: 0001354457-22-000658
CONFORMED SUBMISSION TYPE: 25-NSE
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20221121
DATE AS OF CHANGE: 20221121
EFFECTIVENESS DATE: 20221121
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001337553
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203109565
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 221403634
BUSINESS ADDRESS:
STREET 1: 4301 EMPEROR BOULEVARD
STREET 2: SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: (919) 237-5300
MAIL ADDRESS:
STREET 1: 4301 EMPEROR BOULEVARD
STREET 2: SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: The Nasdaq Stock Market LLC
DATE OF NAME CHANGE: 20060224
25-NSE
1
primary_doc.xml
X0203
0001354457
Nasdaq Stock Market LLC
0001337553
AERIE PHARMACEUTICALS INC
001-36152
135 US Highway 206
Suite 15
Bedminster
NJ
NEW JERSEY
07921
908-470-4320
Common Stock
17 CFR 240.12d2-2(a)(3)
Tara Petta
Vice President
2022-11-21
EX-99.25
2
aeri-form25.txt
aeri-form25